Banque Cantonale Vaudoise Bio N Tech Se Transaction History
Banque Cantonale Vaudoise
- $2.43 Billion
- Q3 2024
A detailed history of Banque Cantonale Vaudoise transactions in Bio N Tech Se stock. As of the latest transaction made, Banque Cantonale Vaudoise holds 323 shares of BNTX stock, worth $38,288. This represents 0.0% of its overall portfolio holdings.
Number of Shares
323
Previous 2,474
86.94%
Holding current value
$38,288
Previous $199,000
80.9%
% of portfolio
0.0%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding BNTX
# of Institutions
357Shares Held
38.3MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.31MShares$985 Million0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$535 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.36MShares$517 Million2.05% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$225 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$214 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $28.8B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...